Global orthokeratology market size is estimated to be valued at USD 442.7 Mn in 2025 and is expected to reach USD 635.9 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.3% from 2025 to 2032.
To learn more about this report, Download Free Sample
Global Orthokeratology Market growth is driven by increasing awareness about the benefits of orthokeratology such as reversibility and the temporary impact of a procedure. Current improvements in technology related to orthokeratology lenses designed to enhance comfort and prolong wear time can aid market growth as well.
|
Event |
Description and Impact |
|
Regulatory Approvals & Policy Changes |
|
|
Technological Innovations
|
|
|
Geopolitical & Trade Dynamics |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
The reimbursement of Orthokeratology (Ortho-K) is affected by policies, global systems, and insurances specifics; however, in the U.S., the system is better documented due to consistency in orthokeratology system state policies.
As it is the case in America, Ortho-K lenses are FDA approved as class II medical devices. Pertinent billing codes are CPT 92060 (fitting of contact lens prosthesis of the eye for treatment encompassing disease), CPT 92071 (supply of a lens), and ICD-10-CM H44.2A (myopia, degenerative) for fulfilling surgical necessity.
Insurance eligibility requires a prior approval based on the clinical documents. Claims must be submitted alongside the necessary CPT/ICD-10 codes, and the providers must keep documentation for audits that justify medical need.
In the United States, medical insurance offers partial reimbursement, ranging from 50% to 70% of the fitting fees, if deemed medically necessary. However, the costs of the lenses are largely out-of-pocket, costing $1,500–$3,000 per year. Vision plans almost always classify Ortho-K as elective and don't reimburse for it. Flexible spending accounts (FSA/HSA) do cover qualifying expenditures, but only on a tax-exempt basis.
Canada and Australia offer limited public healthcare for pediatric or therapeutic cases, while the UK's NHS reimburses for specific instances such as keratoconus. All other markets classify Ortho-K as elective and reimburse reluctantly, if not at all.
Despite an estimated industry growth rate (CAGR) of 6.2%, 85% of the costs associated with Ortho-K are still borne by the patients. Furthermore, the reimbursement limit set by insurers is $500 a year, and only 15% of American insurers offer partial coverage. The cost of maintaining high-performance lens materials and multiple follow-up appointments increase the expenses further.
The absence of standardized ICD-10 codes for claim submission makes it more difficult. Advocacy groups are pushing to expand the coverage, spending packages which range from $2,000 - $4,000, help improve cost transparency.
To learn more about this report, Download Free Sample
Wearing orthokeratology lenses overnight improves one's eyesight by temporarily flattening the cornea. This non-invasive method allows corrective vision without dependence on glasses or contact lenses during waking hours. With continuous technological advancements, orthokeratology has proven to be a highly effective option for moderate to high degrees of myopia. Newer lens designs have significantly enhanced the refractive error range that can be treated.
Precision UV technology tailors the lenses to the individual’s needs by correcting the corneal curvature to match the prescription. This achieves the best possible vision outcomes with the least amount of variation. Compared to the past, the precision and efficiency of orthokeratology correction has greatly advanced. Advanced methods of lens characterization facilitate corneal mapping with ultra-high resolution. This, along with advanced techniques for lens profiling, allows the creation of unique lenses designed to fit the specialized eye parameters of every patient.
Clinically validated results indicate that orthokeratology can at least accurately and dependably address myopia up to a severity of −6.00 diopters and astigmatism up to −1.50 diopters. Some advanced lens designs even expand the treatment spectrum to low hyperopia. The development of new technological tools has made orthokeratology more widely accepted as an effective non-invasive surgery alternative for moderate to high ametropia.
Growing popularity of orthokeratology among the Young people can drive the market growth. Teenagers and young adults form a major end user segment for vision correction products. For this digitally active generation constantly engaged with screens, dependence on glasses can be quite problematic.
Contact lenses provide an alternative but require daily maintenance and handling. Orthokeratology lenses have gained popularity within this group due to their convenience of overnight wear with clear vision during the day. Orthokeratology avoids risks of visual side effects that may arise from extended contact lens usage at a young age. Orthokeratology improves self-esteem and quality of life for teenagers with moderate to high myopia. The confidence boost from not having to wear glasses plays an important psychological role during formative years.
Many orthokeratology adopters use it mainly for the convenience aspect, until these stabilize refractive error progression and consider more permanent vision correction options later in life. Favorable opinions shared on social media platforms have further boosted the acceptance of orthokeratology among young consumers globally. Lens manufacturers recognize this important demographic pillar and tailor appropriate marketing strategies accordingly.
Developing regions present significant growth potential for the global orthokeratology market due to their rapid economic development, increasing disposable incomes, and improved access to healthcare services. Rising living standards increases awareness about vision correction options, thus, boosting popularity of orthokeratology. High-potential areas include Asia Pacific, Latin America, the Middle East, and Africa.
Asia Pacific, with its high myopia rates, and Africa, projected to see a population surge, both offer large untapped markets. Supportive government initiatives, like India's 'Vision Fast Track Initiative,' can also offer growth opportunities. With targeted marketing and affordable products, orthokeratology companies can capture substantial market share in these developing regions.
In terms of product type, overnight ortho-K lenses segment is estimated to contribute the highest Orthokeratology market share of 59.6% in 2025, owing to their convenience and effectiveness. Overnight lenses offer patients the flexibility to simply wear their lenses overnight and remove them in the morning. This allows patients to avoid the hassle of wearing lenses during waking hours, and giving their eyes extended periods of rest.
The results with overnight wear is similar to that of using the device during the day when it comes to correcting low and moderate levels of myopia. Orthokeratology operates by controlled reshaping of the cornea while a person sleeps. Overnight corneal molds are capable of achieving the desired shape changes through a constant light force which is applied overnight. This effectiveness for treatment has made overnight lenses a preferred choice.
In terms of material, fluorosilicone acrylate segment is estimated to contribute the highest Orthokeratology market demand share of 40.71% in 2025, due to its advanced material properties. Fluorosilicone acrylate lenses are highly breathable and flexible. This allows them to move smoothly with blinking and reduce irritation. The material is designed to maximally oxygenate the cornea even during long periods of wear. This provides patients increased comfort levels.
The enhanced elastic properties of fluorosilicone acrylate allows it to gently reshape the cornea with minimal force, reducing risk of complications. The biocompatibility of this material has also been shown to support corneal health. These superior properties have increased patient satisfaction with fluorosilicone acrylate lenses.
In terms of application, myopia segment is estimated to contribute the highest market share of 52.5% in Orthokeratology market forecast 2025, due to high and growing prevalence of myopia globally. Myopia is one of the most common vision conditions affecting people of all ages. In particular, its early onset and continued rise in pediatric populations have elevated demand for myopia control treatments such as orthokeratology.
The prevalence of myopia in children has doubled over the past few decades. With growing use of digital devices and reduced outdoor time implicated as risks for faster myopia progression in young years, early intervention has become a priority. Orthokeratology enables non-invasive treatment of low to moderate myopia through overnight wear of corrective lenses and slowing further increases in nearsightedness.
To learn more about this report, Download Free Sample
North America is projected to dominate the global orthokeratology market with an estimated share of 38.8% in 2025. This regional leadership is backed by the strong presence of major industry players such as Johnson & Johnson Vision and Bausch & Lomb, both headquartered in the U.S. These companies benefit from well-established manufacturing and R&D facilities, enabling efficient local supply and innovation.
The U.S. and Canada continue to see high adoption of orthokeratology, supported by favorable reimbursement policies and a growing preference for non-invasive vision correction technologies. In 2024, leading players expanded their product portfolios to cater to increasing consumer interest in overnight vision correction lenses.
Asia Pacific is emerging as the fastest-growing region in the global orthokeratology market trend, driven by rising demand from China and India. In 2025, this surge is fueled by rising disposable income, a large myopic population, and increased awareness of non-surgical vision correction.
China continues to play a pivotal role, with high adoption rates among students and strong government focus on eye health. Local manufacturers are also gaining traction by offering cost-effective solutions, boosting both affordability and market penetration. In 2024, medical tourism and school-based screening initiatives further accelerated demand in countries such as South Korea and Southeast Asian nations.
The U.S. strengthens its position as the key driver of North America’s orthokeratology market through a combination of technological innovation, consumer willingness to adopt advanced eye care solutions, and supportive reimbursement frameworks. In 2024, U.S.-based companies expanded their outreach through digital health platforms and targeted campaigns aimed at promoting orthokeratology as a safe and effective option for myopia control among children and teens.
China holds a commanding position in the Asia Pacific orthokeratology landscape, attributed to its vast population, rising awareness of eye health, and escalating rates of childhood myopia. In 2025, the country’s market is supported by government-led myopia prevention strategies, as well as increasing access to affordable and branded orthokeratology lenses. In 2024, collaborations between local and global manufacturers led to new product introductions tailored for pediatric use, further propelling market momentum.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 442.7 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 5.3% | 2032 Value Projection: | USD 635.9 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Bausch + Lomb, Johnson & Johnson Vision, CooperVision, GP Specialists, Paragon Vision Sciences, Alpha Corporation, Euclid Systems Corporation, Procornea, Art Optical Contact Lens, Inc., Brighten Optix, Menicon, E&E Optics, Autek China, Precilens, AOK Group, Gelflex, Essilor International S.A., TFOS Orthokeratology |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
*Definition: Global Orthokeratology Market involves the design, development, and manufacturing of contact lenses used for overnight orthokeratology, a non-surgical alternative to correct refractive errors like myopia and hyperopia. The orthokeratology contact lenses are specially designed to gently reshape the cornea while worn overnight to temporarily improve vision without glasses or contact lenses during waking hours. Global leaders in this market supply orthokeratology lenses and related products globally to optometrists and consumers looking for non-invasive vision correction solutions.
Share
Share
About Author
Ghanshyam Shrivastava - With over 20 years of experience in the management consulting and research, Ghanshyam Shrivastava serves as a Principal Consultant, bringing extensive expertise in biologics and biosimilars. His primary expertise lies in areas such as market entry and expansion strategy, competitive intelligence, and strategic transformation across diversified portfolio of various drugs used for different therapeutic category and APIs. He excels at identifying key challenges faced by clients and providing robust solutions to enhance their strategic decision-making capabilities. His comprehensive understanding of the market ensures valuable contributions to research reports and business decisions.
Ghanshyam is a sought-after speaker at industry conferences and contributes to various publications on pharma industry.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
Schedule a meeting with report Author
